Pharmaceutical Technology, June 2010 Issue (PDF)
Excipients Step into the Spotlight
Anniversary Season
The birth of "the pill" and harmonization created a new paradigm for global standards.
Outsourcing Clinical Trial Development and Materials
CROs and CMOs adapt their business models and capabilities to meet sponsor companies' need to reduce costs and accelerate development time.
Leveling the Compliance Playing Field
The author suggests industry may need a NATO-type organization to even out inspections.
Industry and regulatory experts discuss excipient testing, regulatory expectations, supply-chain challenges, and pricing in this Speakers Roundtable. This article contains bonus online material and podcasts.
EU Debt Crisis Adds Uncertainty
The sovereign debt crisis in the EU could greatly change the landscape for contract services.
Puerto Rico Builds a Foundation for Biopharmaceuticals
Puerto Rico, long a mainstay of solid-dosage manufacturing, intensifies efforts in biopharmaceutical manufacturing and research and development.
Even Packaging Can Multitask
Interphex attendees found packaging machines and containers with increased functionality. This article contains online bonus material.
Securing the Supply Chain
FDA and industry seek to ensure drug quality and safety in a world complicated by global outsourcing and rising theft.
A Q&A with Uwe Ross of Binder
The president of Binder, a manufacturer of simulation chambers, addresses the consolidation of Big Pharma, and more.
Making a Difference
A PharmTech forum to discuss the industry's efforts in corporate social responsibility and sustainability.
Inside USP: Positioned for Growth
USP membership meeting prepared the standards-setting body to meet modern challenges.
In the Spotlight June 2010
Editors' picks of pharmaceutical science and technology innovations.
Biopharmaceutical Form and Function
A timely new book explains techniques for conformational analysis.
Report from Europe
Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.
Everybody's Got Problems
Too much or too little control can actually lead to the same result.
A Risk-Management Approach to Cleaning-Assay Validation
The authors recommend a strategy for classifying similar nonstainless-steel surfaces into three groups based upon the analytical recovery that was observed in this study.
